Kaneka Americas Holdings Inc. has achieved Health Canada Class III approval for Floradapt Cardio under the Natural Health Products Directorate
Photo © Shutterstock.com/AlexLMX
Kaneka Americas Holdings Inc. (Newark, CA) has achieved Health Canada Class III approval for Floradapt Cardio under the Natural Health Products Directorate. The product is identified by the Natural Product Number (NPN) 80096187.
“With this approval from Health Canada, we are providing dietary supplement companies an innovative way to engage the cardiovascular market,” said Mike Kolifrath, vice president, sales and marketing for Kaneka’s probiotics division, in a press release.
The NPN allows Floradapt Cardio to carry the following claims in Canada:
• Helps to reduce levels of total cholesterol in men and women with hypercholesterolemia.
• Helps support healthy cholesterol level in hypercholesterolemic patients
• Supports cardiovascular health by contributing to healthy serum cholesterol in hypercholesterolemic patients
• Helps support intestinal / gastrointestinal health
• Could promote a favorable gut flora
• Source of probiotics
The NPN for Floradapt Cardio is one of a number of regulatory milestones for Kaneka’s line of probiotics. Prior to this, Kaneka announced self-affirmed GRAS status for its Baby Colic and Intensive G.I. probiotic formulations.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.